What question did this study set out to answer?

To develop and evaluate a viscoelastic-based microfluidic platform for direct, label-free isolation of small extracellular vesicles (sEVs) from human blood.

October 6, 2023Science AdvancesOpen Access

Direct isolation of small extracellular vesicles from human blood using viscoelastic microfluidics

View Full Paper

Ask AI

Bookmark

Authors

YMYingchao Meng YZYanan Zhang MBMarcel Bühler

Discussion

Member takes

Overview

Experimental study demonstrates efficient label-free isolation of small extracellular vesicles from human blood, indicating viable clinical utility for cancer biomarker detection.

Key Points

To develop and evaluate a viscoelastic-based microfluidic platform for direct, label-free isolation of small extracellular vesicles (sEVs) from human blood.
Engineered a viscoelastic microfluidic platform designed to separate sEVs (<200 nm) directly from whole blood without molecular labeling.
Quantified isolation purity and recovery efficiency using fluorescent sEVs, comparing yield and proteomic profiles against standard ultracentrifugation.
Evaluated clinical utility using blood samples collected from 20 cancer patients and 20 healthy donors.
Achieved sEV isolation purities exceeding 97% and recovery rates exceeding 87% from whole blood.
Demonstrated higher sEV yields compared to ultracentrifugation, while retaining consistent sEV proteomic compositions.
Identified significantly higher blood sEV concentrations in 20 patients with cancer compared to 20 healthy controls.

Cite This Study

Meng et al. (2023) studied this question.

synapsesocial.com/papers/69d8d33013e0539d74bedaea https://doi.org/10.1126/sciadv.adi5296

View Full Paper

Ask AI

Bookmark

October 6, 2023Science AdvancesOpen Access

Direct isolation of small extracellular vesicles from human blood using viscoelastic microfluidics

View Full Paper

Ask AI

Bookmark

Authors

YMYingchao Meng YZYanan Zhang MBMarcel Bühler

Discussion

Member takes

Overview

Experimental study demonstrates efficient label-free isolation of small extracellular vesicles from human blood, indicating viable clinical utility for cancer biomarker detection.

Key Points

To develop and evaluate a viscoelastic-based microfluidic platform for direct, label-free isolation of small extracellular vesicles (sEVs) from human blood.
Engineered a viscoelastic microfluidic platform designed to separate sEVs (<200 nm) directly from whole blood without molecular labeling.
Quantified isolation purity and recovery efficiency using fluorescent sEVs, comparing yield and proteomic profiles against standard ultracentrifugation.
Evaluated clinical utility using blood samples collected from 20 cancer patients and 20 healthy donors.
Achieved sEV isolation purities exceeding 97% and recovery rates exceeding 87% from whole blood.
Demonstrated higher sEV yields compared to ultracentrifugation, while retaining consistent sEV proteomic compositions.
Identified significantly higher blood sEV concentrations in 20 patients with cancer compared to 20 healthy controls.

Cite This Study

Meng et al. (2023) studied this question.

synapsesocial.com/papers/69d8d33013e0539d74bedaea https://doi.org/10.1126/sciadv.adi5296

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark